Publication | Closed Access

Liraglutide, a GLP-1 receptor agonist, inhibits vascular smooth muscle cell proliferation by enhancing AMP-activated protein kinase and cell cycle regulation, and delays atherosclerosis in ApoE deficient mice

InflammationGlp-1 Receptor AgonistApoe Deficient MiceAtherosclerosisCell Cycle RegulationPhysiologyMedicineVascular PharmacologyEndothelial DysfunctionVascular BiologyPharmacologyCell BiologyCell SignalingCellular Physiology